What is the content of the report?
The report contains the following data and information:
- value and growth rate of the market for biologic medicines in Poland, with a breakdown into reference biologics and biosimilars, and into outpatient medicines (pharmacy sales) and hospital medicines (therapeutic programmes & chemotherapy)
- growth prospects – for the total market and for main product categories (with a breakdown into reference biologics and biosimilars)
- market structure
- profiles of leading players (with a breakdown into reference biologics and biosimilars)
- best-selling products (with a breakdown into reference biologics and biosimilars)
- main categories of biologic medicines
- latest trends and developments and their impact on the biologics market
- anticipated trends and developments and their impact on the biologics market
- key market growth factors and inhibitors
- epidemiological trends
And additionally:
- exclusive PMR analyses and estimates of the value of the market for reference biologics and biosimilars in Poland in 2017-2019, together with our own classification of medicines
- findings from two new PMR studies: a poll of market players, and a survey of physicians
- key changes in the reimbursement list pertaining to biologic medicines
- expiry of patents for important biologic medicines
